CCOLA:BISTCoca-Cola Icecek A.S. Analysis
Data as of 2026-03-16 - not real-time
TRY 70.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
CCOLA is trading at 70 TRY, below its 20‑day SMA of 72.28 and 50‑day SMA of 71.09 but above the 200‑day SMA of 56.14, showing longer‑term bullish bias. The 14‑day RSI sits at 46.7, near the neutral zone, while the MACD histogram remains negative (-0.32) and the signal line is flagged “bearish,” hinting at potential short‑term downside pressure. Volatility over the past 30 days is high at 40.7% and beta is only 0.22, meaning price swings are pronounced but largely uncorrelated with the broader market. Support is identified around 64.95 TRY and resistance near 80.40 TRY, giving the stock a ~10% upside to the next technical ceiling. The dividend yield of 2.04% with a modest payout ratio of 21% adds income appeal despite the technical headwinds.
Fundamentally, the company posted a 19% revenue surge, delivering 187.2 bn TRY in sales and a healthy operating margin of 10.1%. Forward earnings are projected at 9.35 TRY per share, translating to a forward P/E of 7.5x, well below the current trailing P/E of 13.9x. The DCF‑derived fair value of 58.9 TRY suggests the market is pricing a premium, yet analyst consensus targets average 91.9 TRY, implying roughly 30% upside. With a strong cash position of 26.3 bn TRY versus debt of 52.1 bn TRY (D/E ≈ 60), the balance sheet can comfortably sustain the dividend and fund modest growth. Given the defensive consumer‑staples positioning, low beta, and attractive yield, the stock appears undervalued and suitable for a buy‑and‑hold strategy.
Fundamentally, the company posted a 19% revenue surge, delivering 187.2 bn TRY in sales and a healthy operating margin of 10.1%. Forward earnings are projected at 9.35 TRY per share, translating to a forward P/E of 7.5x, well below the current trailing P/E of 13.9x. The DCF‑derived fair value of 58.9 TRY suggests the market is pricing a premium, yet analyst consensus targets average 91.9 TRY, implying roughly 30% upside. With a strong cash position of 26.3 bn TRY versus debt of 52.1 bn TRY (D/E ≈ 60), the balance sheet can comfortably sustain the dividend and fund modest growth. Given the defensive consumer‑staples positioning, low beta, and attractive yield, the stock appears undervalued and suitable for a buy‑and‑hold strategy.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Negative MACD histogram
- Price below short‑term SMAs
- Attractive dividend yield
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Forward P/E of 7.5x
- Revenue growth of 19%
- Analyst target price indicating 30% upside
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Strong brand franchise
- Defensive consumer staples sector
- Low beta and stable cash flow
Key Metrics & Analysis
Financial Health
Revenue Growth19.10%
Profit Margin7.52%
P/E Ratio13.9
ROE17.05%
ROA8.16%
Debt/Equity60.16
P/B Ratio2.6
Op. Cash FlowTRY27.4B
Free Cash FlowTRY6.4B
Technical Analysis
TrendBullish
RSI46.7
SupportTRY 64.95
ResistanceTRY 80.40
MA 20TRY 72.28
MA 50TRY 71.09
MA 200TRY 56.14
MACDBearish
VolumeStable
Fear & Greed Index72.88
Valuation
Fair ValueTRY 58.93
Target PriceTRY 91.85
Upside/Downside31.22%
GradeUndervalued
TypeGrowth
Dividend Yield2.04%
Risk Assessment
Beta0.22
Volatility40.70%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskHigh
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.